"The U.S. Food and Drug Administration today approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections.
Sivextro is approved to treat patients with acute bacterial skin and skin structure infecti"...
Cordran® Lotion is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsivedermatoses.
DOSAGE AND ADMINISTRATION
Shake well before using. A small quantity of Cordran Lotion should be rubbed gently into the affected area 2 or 3 times daily.
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.
Cordran® Lotion should not be used with occlusive dressings unless directed by a physician. Tight-fitting diapers or plastic pants may constitute occlusive dressings.
Cordran® Lotion, 0.05% is supplied in plastic squeeze bottles as follows:
15 mL (NDC 16110-052-15);
60 mL (NDC 16110-052-60)
120 mL (NDC 16110-052-12)
Keep out of reach of children.
Avoid freezing. Keep tightly closed. Protect from light.
Store at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) [See USP controlled room temperature]
Marketed by: Aqua Pharmaceuticals, LLC, West Chester, PA 19380 USA. Under License from: Watson Laboratories, Inc. Corona, CA 92880 USA. Manufactured by: DPT Laboratories, Ltd. San Antonio, TX 78215 USAThis monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 8/5/2011
Additional Cordran Lotion Information
Cordran Cream - User Reviews
Cordran Cream User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.